Investigating the effect of oral magnesium supplementation on cognitive function, fatigue, depression, anxiety of multiple sclerosis patients
Not Applicable
- Conditions
- Multiple Sclerosis.Multiple sclerosis
- Registration Number
- IRCT20220101053582N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 58
Inclusion Criteria
The individual's willingness to participate in the study
Definite patients with relapsing-remitting MS based on the 2017 McDonald diagnostic criteria (20) who are on file at Sinai Hospital
Age range 18-55 years
EDSS less than 5.5
Education above diploma
More than one month has passed since the last corticosteroid injection (pulse therapy)
More than one month has passed since the last relapse of the disease
Exclusion Criteria
Suffering from another neurological disease other than MS
Pregnancy or breastfeeding
Suffering from chronic gastrointestinal, liver, kidney, heart, respiratory and cancer diseases
Having a diet for any reason
Suffering from severe psychological disorders such as major depression
History of allergy to Magnesium
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method